TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GEBE Medicinsk och Bioteknisk Konsult AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
219
|
145
|
48 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,237
|
-22
|
-284 |
| EBITDA |
1,198
|
-9
|
-270 |
| Total assets |
2,634
|
1,377
|
1,712 |
| Current assets |
2,634
|
326
|
553 |
| Current liabilities |
252
|
19
|
78 |
| Equity capital |
2,341
|
1,328
|
1,606 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
88.9%
|
96.4%
|
93.8% |
| Turnover per employee |
110
|
72
|
24 |
| Profit as a percentage of turnover |
564.8%
|
-15.2%
|
-591.7% |
| Return on assets (ROA) |
47.0%
|
-1.6%
|
-16.6% |
| Current ratio |
1045.2%
|
1715.8%
|
709.0% |
| Return on equity (ROE) |
52.8%
|
-1.7%
|
-17.7% |
| Change turnover |
73
|
101
|
11 |
| Change turnover % |
50%
|
229%
|
29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.